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ABSTRACT 
FSL constructs (KODE Biotech Limited) consist of 3 parts: a 
functional head group (F), a spacer (S) and a lipid tail (L).  
The lipid tail acts as an anchor to localise the functional head 
group to a lipophilic surface, e.g. a cell membrane.  In 
addition to satisfying the requirement for biocompatibility, 
the ability of the FSL constructs to disperse easily in water 
allows solutions of the constructs to be substituted for the ink 
in inkjet printer cartridges.  FSL constructs can then be 
printed onto solid surfaces using a standard desktop printer 
and are being used to develop prototype diagnostic assays 
(Bovin et al, 2011).  The constructs can be printed as words 
or in desired patterns.  FSL constructs comprising ABO blood 
group antigens or biotin as the functional head groups (F) 
have been printed onto silica, nitrocellulose and paper.  The 
printed constructs have then been used to identify antibodies 
in different biological samples.  The inkjet printing of FSL 
constructs provides the advantage that multiple antibodies can 
be identified and quantified in the same reaction well.  The 
inkjet printing of FSL constructs is proving to be a fast, 
inexpensive and flexible method of producing diagnostic 
assays.    
INTRODUCTION 
 KODE™ Technology (KODE Biotech Limited) is a 
platform technology that allows antigens or other epitopes to 
be stably, easily and controllably incorporated into 
membranes by the use of FSL constructs (Frame et al., 2007; 
Henry, 2009; Heathcote et al., 2010).  FSL constructs 
containing carbohydrates, peptides, fluorophores and biotin 
as the functional head group (F) are currently available 
(www.kodebiotech.com).  Simple mixing of cells with a 
solution of these constructs allows the functional head group 
(F) to be localised to the cell membrane, creating modified 
cells referred to as “kodecytes”.  The amount of antigen 
localised to the cell surface is controllable.   Kodecytes are 
currently used as control cells for blood grouping (Henry, 
2009).  Due to the novel properties of FSL constructs many 
other applications are possible.  In particular, the dispersiblity 
of the constructs in water makes them ideal for use as “bio-
ink” or “bio-glue” in inkjet printing. 
 Inkjet printing is an interesting and emerging technology in 
many different areas and is providing a fast, inexpensive and 
flexible method of delivering many different materials, 
including bio-molecules, to different surfaces. Its advantages 
of being precise and reliable have given it applications in 
electronics and optics (Calvert, 2001; Cooley et al., 2002), 
which have been extended to biomaterials and biomedical 
devices.  The droplets can be in the picolitre to microlitre 
range making inkjet technology desirable for printing 
proteins, nucleic acids and cells in the fabrication of 
biosensors, microarrays, tissues and organs.   Fluid micro-
dispensing in this manner allows non-contact delivery of 
droplets into exact positions offering a precise tool for bio-
surface and tissue engineering (Boland et al., 2007; Boland et 
al., 2006).   
 Standard inkjet printers have been employed to deliver 
various molecules for a range of applications. Both thermal 
and piezoelectric inkjet printers have been shown to 
successfully print proteins.  Examples include 
immunoglobulins for ELISA plates (Lonini et al., 2008),  
multi-analyte patterning of biotinylated proteins and thiols on 
gold substrates to create biosensors, and HRP (horseradish 
peroxidase) enzyme patterning in microfluidic paper-based 
devices (Khan et al., 2010).   These proteins remained active 
after printing and any degradation was shown to be 
insignificant, indicating shear or heat stresses did not damage 
the molecules in the process. 
 Cells have also been printed using inkjet technology.  Cell 
patterning and printing offers the potential to produce 3D 
cellular structures in a layer-by-layer process with a goal of 
printing organs and tissues for transplantation or testing 
purposes.  Organ printing has been defined as computer 
aided, inkjet 3D tissue engineering (Mironov et al., 2003) and 
the feasibility of printing viable cells has been demonstrated.  
Xu et al. (2005)  used a thermal printer to deliver mammalian 
cells to hydrogels, which proliferated and differentiated 
indicating the cells survived the stress and heat of printing.  
This technology presents a method of simultaneously 
delivering a variety of cells along with growth factors and 
nutrients to allow cells to fuse and grow into desired 
structures.  
 The research reported here is focusing on the reactions in 
immunoassays of printed FSL constructs, the mechanism of 
immobilization, and onto what surfaces the FSL constructs 
can be printed.  We are now determining if cells can be 
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attached to printed FSL constructs and then if kodecytes 
themselves can be printed.  
I  MATERIALS AND METHODS 
A. Printer Setup and Printing Solutions 
An Epsom Stylus T21 piezoelectric inkjet printer was used 
to print the solution of FSL constructs (Fig 1).  Epsom 
cartridges use a sponge to ensure a constant pressure of ink 
on the nozzles.  Due to cleaning and the large volume 
required to refill these cartridges, sponge-less, refillable 
cartridges were obtained and were modified to allow small 
volumes (<1 ml) to be injected into the cartridge.  Cartridges 
were filled by connecting a tube to a sealed chamber above 
the ink outlet.   The cartridges were cleaned with 70% ethanol 
and DI water before adding printing solutions.    
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Epsom Stylus T21 piezoelectric printer used to print FSL 
constructs. 
 
Three FSL constructs were obtained (KODE Biotech 
Limited):  
‘FSL-A’ with a blood group A trisaccharide epitope 
GalNAca3(Fuca2)Galb (FSL-A(GALNa3[Fa2]GALb)-SA1-
L1, cat # 421604);  
‘FSL-B’ with a blood group B trisaccharide epitope 
Gala3(Fuca2)Galb (FSL-B(GAL3[Fa2]GALb)-SA1-L1, cat # 
199283); and  
‘FSL-biotin’ with a single biotin  moiety as the functional  
head group (F) (FSL-CONJ(1Biotin)-SC2-L1, cat # 187786).  
Solutions containing 1mg/ml concentration of each FSL 
construct were prepared for printing in phosphate buffered 
saline (PBS), pH 7.2.  The dye bromophenol blue was 
included in the solution at a concentration of 0.5% so the 
printed area could be observed.  The functional moiety (F) of 
the FSL constructs was also printed, e.g. the A trisaccharide 
(F) of FSL-A. 
Patterns were designed using standard graphics software.  
The colour management of the printer was adjusted to print 
the desired solution from the correct cartridge.   Most desktop 
printers will mix inks from different cartridges to produce the 
majority of colours.  It was important to be able to print 
specifically from one cartridge or multiple cartridges 
containing different solutions of FSL constructs. 
The printer was primed by simulating the printing of blocks 
of colour after inserting the cartridge.   This removed air 
bubbles and pulled the printing solution through to the print 
head.  Epsom printheads are located inside the printer and not 
on the cartridge as with other printers.  It is important to 
ensure the solution has flowed though the system to the print 
head.  Printing surfaces were threaded through the printer 
using the paper feeder.  All surfaces were flexible enough to 
be able to be printed on in this way.  After printing the 
surfaces were dried and stored at RT. 
For some assays 3mm clear acrylic plates with 32 holes 
were attached to the printed surfaces to create reaction wells. 
These plates were designed to fit the footprint of half a 
microwell plate.  This enabled the fabricated microwell plates 
to be compatible with automatic equipment used for 
microwell ELISAs (Enzyme-Linked Immunosorbent Assay).  
The acrylic plates were produced by laser cutting 32 wells 
using the same template produced for printing the FSL 
constructs (Fig 2).  This enabled exact matching of the 
printed areas and the holes to create 32 discrete reaction wells 
on one plate.  The printed surface was washed in deionised 
(DI) water for 30 minutes, air dried, and the acrylic plate then 
glued to the printed surface using multipurpose spray glue.  
The blank wells are then ready for immunostaining/testing. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. Acrylic plate cut with 32 holes for reaction wells. 
 
B. Printing Surfaces 
Surfaces printed onto include silica thin layer 
chromatography (TLC) plates (silica 60), nitrocellulose 
(0.2µm pore size), standard office printer paper, a variety of 
coated papers, fabrics and transparent overhead projector 
plastic. 
C. Immunostaining 
Surfaces were washed with DI water for 30 minutes to 
remove the printing dye and air dried.  The surface appeared 
blank at this stage.  Surfaces were then blocked with bovine 
serum albumin (BSA) for 1 hour at room temperature (RT) to 
prevent non-specific binding.   The BSA was removed and 
the surface incubated with antibody or binding molecule at 
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the required concentration for 1 hour at RT. For blood group 
antigens this was monoclonal or polyclonal antibodies.  For 
biotin this was streptavidin conjugated to alkaline 
phosphatase.  The surfaces were then washed 6 times in PBS 
to remove unbound molecules followed by incubation with a 
1 in 400 dilution in BSA of the secondary antibody or binding 
molecule conjugated to alkaline phosphatase for 30 minutes 
at RT.  For blood group antigens the secondary antibody was 
species-specific anti-Ig.  For biotin, no secondary molecule 
was used as a conjugate was used in the primary binding.   
The surfaces were washed again 6 times in PBS and once in 
tris substrate buffer pH 9.5.  A 1 in 50 dilution of the 
chromogenic substrate NBT/BCIP (nitro blue tetrazolium 
chloride / 5-bromo-4-chloro-3-indolyl phosphate, toluidine 
salt (Roche)) in substrate buffer (pH 9.5) was then flooded 
over the surfaces for 15-30 minutes.  The alkaline 
phosphatase converts the substrate from a yellow to a dark 
purple which is easily readable.  The areas where the 
antibodies or binding molecules have attached are clearly 
visible.  Membranes were washed in DI water to stop the 
reaction.  
II. RESULTS 
A. Blood Group Antigen FSLs 
FSL-A and FSL-B have been printed onto different 
surfaces in a variety of designs.  When printed alongside A 
trisaccharide and B trisaccharide only the FSL molecule was 
detected.  This indicates that printing in the form of the FSL 
construct is required to localise these molecules to the surface 
and that the trisaccharides on their own were washed away 
during the immunostaining process.   Fig 3 shows a format 
where the FSL-A was printed with the well coordinate.  The 
positive reactions are easily identified and traceable as they 
read the location of the positive reaction.  Fig 4 shows a well 
where FSL-A has been printed in a ladder format in 
increasing amounts from 0 to 100% using the grey scale on 
the printer.  The numbers printed alongside are assigned to 
each band of the ladder and would indicate at which point the 
reaction stops, i.e. how much antibody is in the sample.  The 
option to include as a positive control the printing of a 
construct that would react with all serums is available.  The 
numbers presented in these results were printed in font size 6 
and are easily readable with the naked eye. 
Fig 5 shows FSL-A and FSL-B printed onto paper and 
reacted with polyclonal human O serum, which contains 
antibodies to A and B antigens.  Both the A (FSL-A) and B 
(FSL-B) were visible in the well, showing the antibodies in 
the serum had bound to the immobilised antigens, and hence 
were detected using the colorimetric system.  The unprinted 
area surrounding the printed letters acts as a negative control 
and the background signal, hence each well has the possibility 
of including a positive and negative control.   
Fig 6 shows the structure of FSL-A printed, using FLS-A as 
the ink, onto paper and immunostained using monoclonal 
anti-A, representing the flexibility inkjet printing offers.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. The well coordinate printed using FSL-A at a 
concentration of 1mg/ml onto silica, attached to an acrylic plate and 
4 wells immunostained with monoclonal anti-A at decreasing 
concentrations.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4. FSL-A printed onto silica in a ladder format in decreasing 
amounts, attached to an acrylic plate and immunostained with 
monoclonal anti-A.    
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5. FSL-A and FSL-B printed onto paper at a concentration of 
1mg/ml, attached to an acrylic plate and immunostained with 
polyclonal serum.  
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Fig. 6. The structure of FSL-A  printed onto a coated paper with 
FSL-A, at a concentration of 1mg/ml. 
 
B. Other FSL constructs 
FSL-biotin has been printed onto various surfaces.  Biotin is a 
water soluble vitamin and is used widely in biological 
applications due to its high affinity for the tetrameric protein 
avidin.  Being able to immobilise biotin to different surfaces 
allows the opportunity to attach a wide variety of molecule to 
these surfaces through the avidin-biotin bond, one of the 
strongest known in non-covalent protein-ligand attachments.   
 
Fig. 7. FSL-biotin printed at a concentration of 1mg/ml onto 
standard printer paper, stained with streptavidin conjugated to 
alkaline phosphatase, and NBT/BCIP substrate.  
III. DISCUSSION 
This research is focused on the inkjet printing of FSL 
constructs for use in the fabrication of microarrays and 
diagnostics assays, and eventually for the immobilization of 
living cells (Henry, 2011).   FSL constructs permit multiple 
antigens and epitopes to be localised to surfaces using the 
same methodology.  It is the lipid tail (L) of the FSL 
constructs that enables the functional head groups (F) to be 
localised to the surfaces.  A and B trisaccharides lacking this 
lipid tail are not detected in the assays employed here.  It is 
assumed the trisaccharides are washed away during the 
blocking and washing steps of the assays.   
Inkjet printing of blood group antigens and peptides of 
blood transferable diseases creates a fast, inexpensive and 
flexible method of developing diagnostic assays.  The format 
of these assays can range from wells in an acrylic plate, 
compatible with automation equipment, to dipstick assays 
easily used in developing countries.  All assays are carried out 
at room temperature and don’t require any sophisticated 
equipment.  The flexible, digital control inherent in inkjet 
printing means FSL constructs can be printed as words, 
barcodes, or patterns of any shape or size to create bioactive 
areas capable of detecting multiple antibodies in biological 
samples.  As well as blood group assays, this technique can 
be extended to diseases where multiple antigens can be 
printed in the words of each disease, creating a multiplex 
assay capable of detecting many different antigens at the same 
time with a very small amount of blood.   
The technology can potentially allow any antigen to be 
localised to a surface and therefore has great potential for 
developing biological assays and diagnostics tests.  There is 
also potential to immobilise cells and/or kodecytes onto 
surfaces printed with FSLs to create layers of cells.  These 
could be the initial steps in the construction of 3D structures, 
printing multiple cell layers which will fuse together (Henry, 
2011).    
IV.  CONCLUSION AND FUTURE WORK 
Inkjet printing of FSL constructs is fast, precise and 
versatile making it highly suited for bio-assay development, 
multi-analyte tests and tissue engineering.  
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